Grace Bio-Oncology, Inc. – Trademark Portfolio

Entity Type: 03

Grace Bio-Oncology, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ONCYTE. The owner is based in Pontiac, MI.

Pontiac, MI 48057

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ONCYTE
ONCYTE
Registered 1993

Trademark Classifications

Grace Bio-Oncology, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Grace Bio-Oncology, Inc. have?

Grace Bio-Oncology, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Grace Bio-Oncology, Inc. file in?

Grace Bio-Oncology, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Grace Bio-Oncology, Inc.'s most well-known trademarks?

Grace Bio-Oncology, Inc.'s registered trademark portfolio includes well-known marks such as ONCYTE. These are among 1 currently registered trademark in the portfolio.

What is Grace Bio-Oncology, Inc.'s trademark registration success rate?

Grace Bio-Oncology, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.